Replication-dependent pathogenicity of attenuated nef-deleted HIV-1 in vivo

Journal of Acquired Immune Deficiency Syndromes

Volumn 46, Issue 4, 2007, Pages 390-394

  Gorry, Paul R ^a,b,c   Churchill, Melissa ^a   Learmont, Jennifer ^d   Cherry, Catherine ^a,b,e   Dyer, Wayne B ^d,f   Wesselingh, Steven L ^a,b,c   Sullivan, John S ^d,f  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^e ALFRED HOSPITAL   (Australia)

^f University of Sydney   (Australia)

Author keywords

Attenuated; HIV 1; Long term nonprogressor (LTNP); nef deleted

Indexed keywords

ANTIRETROVIRUS AGENT; NEF PROTEIN; RNA; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD BANK; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL LOSS; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER PROGRAM; DISEASE COURSE; DOCUMENTATION; DRUG BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; GENE; GENE DELETION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VIVO STUDY; MALE; MICROBIAL ATTENUATION; NEF GENE; OUTCOME ASSESSMENT; PATHOGENICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; VIREMIA; VIRUS REPLICATION; VIRUS STRAIN;

AGED; AGED, 80 AND OVER; BLOOD DONORS; CD4 LYMPHOCYTE COUNT; DNA REPLICATION; FEMALE; GENE DELETION; GENES, NEF; HIV INFECTIONS; HIV-1; HUMANS; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGED; RNA, VIRAL; VIRAL LOAD;

EID: 36048985664     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31815aba08     Document Type: Article

References (27)

1. Kestler HW 3rd, Ringler DJ, Mori K, et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 1991;65:651-662.
2. Chakrabarti L, Baptiste V, Khatissian E, et al. Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus. Virology. 1995;213:535-548.
3. Desrosiers RC, Lifson JD, Gibbs JS, et al. Identification of highly attenuated mutants of simian immunodeficiency virus. J Virol. 1998;72:1431-1437.
4. Hofmann-Lehmann R, Vlasak J, Williams AL, et al. Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation. AIDS. 2003;17:157-166.
5. Iafrate AJ, Carl S, Bronson S, et al. Disrupting surfaces of nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo. J Virol. 2000;74:9836-9844.
6. Messmer D, Ignatius R, Santisteban C, et al. The decreased replicative capacity of simian immunodeficiency virus SIVmac239Delta(nef) is manifest in cultures of immature dendritic cells and T cells. J Virol. 2000;74:2406-2413.
7. Deacon NJ, Tsykin A, Solomon A, et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 1995;270:988-991.
8. Kirchhoff F, Greenough TC, Brettler DB, et al. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med. 1995;332:228-232.
9. Mariani R, Kirchhoff F, Greenough TC, et al. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol. 1996;70:7752-7764.
10. Rhodes DI, Ashton L, Solomon A, et al. Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group. J Virol. 2000;74:10581-10588.
11. Kondo M, Shima T, Nishizawa M, et al. Identification of attenuated variants of HIV-1 circulating recombinant form 01_AE that are associated with slow disease progression due to gross genetic alterations in the nef/long terminal repeat sequences. J Infect Dis. 2005;192:56-61.
12. Learmont J, Tindall B, Evans L, et al. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet. 1992;340:863-867.
13. Learmont JC, Geczy AF, Mills J, et al. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N Engl J Med. 1999;340:1715-1722.
14. Churchill MJ, Rhodes DI, Learmont JC, et al. Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source. J Virol. 2006;80:1047-1052.
15. Churchill M, Sterjovski J, Gray L, et al. Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia. J Infect Dis. 2004;190:2181-2186.
16. Crowe SM, Ho DD, Marriott D, et al. In vivo replication kinetics of a nef-deleted strain of HIV-1. AIDS. 2005;19:842-843.
17. Fairley CK, Spelman D, Street A, et al. CD4 lymphocyte numbers after splenectomy in patients infected with the human immunodeficiency virus. Int J STD AIDS. 1994;5:177-181.
18. Geczy AF, Kuipers H, Coolen M, et al. HLA and other host factors in transfusion-acquired HIV-1 infection. Hum Immunol. 2000;61:172-176.
19. Rhodes D, Solomon A, Bolton W, et al. Identification of a new recipient in the Sydney Blood Bank Cohort: a long-term HIV type 1-infected seroindeterminate individual. AIDS Res Hum Retroviruses. 1999;15:1433-1439.
20. O'Brien SJ, Moore JP. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev. 2000;177:99-111.
21. Roger M. Influence of host genes on HIV-1 disease progression. FASEB J. 1998;12:625-632.
22. Verity E, Zotos D, Wilson K, et al. Viral phenotypes and antibody responses in long term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef/long terminal repeat region. J Virol. 2007;81:9268-9278.
23. Gray L, Churchill MJ, Sterjovski J, et al. Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long term survivors infected from a single source. Virology J. 2007;4:75.
24. Churchill M, Chiavaroli L, Wesselingh SL, et al. Persistence of attenuated HIV-1 rev alleles in an epidemiologically linked cohort of long-term survivors infected with nef-deleted virus. Retrovirology. 2007;4:43.
25. Pontesilli O, Klein MR, Kerkhof-Garde SR, et al. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection. J Infect Dis. 1998;178:1008-1018.
26. Riviere Y, McChesney MB, Porrot F, et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res Hum Retroviruses. 1995;11:903-907.
27. Gorry PR, McPhee DA, Verity E, et al. Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Retrovirology. 2007;4:66.